Accretive Health (ACHI) 6.1000 $ACHI
Accretive Health to Present at the 33rd Annual J.P. Morgan Healthcare Conference
Business Wire - Mon Jan 05, 4:50PM CST
Accretive Health, Inc. (OTC Pink: ACHI) today announced its management team will present at the 33rd Annual J.P. Morgan Healthcare Conference on Thursday, January 15th 2015 at 9:00 am PST in San Francisco, where management will discuss the Company's operations and business.
JPM: 59.67 (+0.10)
Accretive Health Completes Financial Restatement and Provides Business Update
Business Wire - Tue Dec 30, 3:00PM CST
--Timing of revenue recognition places emphasis on cash generated from customer contracts; company introduces new non-GAAP measures
Accretive Health - Pending Restatement Offers A 1:4 Risk/Reward With A Near-Term Catalyst
Sententia Capital - Seeking Alpha - Wed Dec 24, 5:00AM CST
Accretive Health - Long Sententia Capital Management December 2014 Ticker: OTCPK:ACHI Mkt cap: $786m Price: $8.60 Intrinsic value: $11 Recommendation : Accretive Health is a buy at $8 with a base case of $11, representing 35%...
Accretive Health Provides Updated Timeline for Completion of Restatement
Business Wire - Fri Dec 19, 6:35PM CST
Accretive Health, Inc. (OTC Pink: ACHI) today announced that it is in the final stages of completing its financial restatement. The Company currently expects to file its Annual Report on Form 10-K for the year ended December 31, 2013 with the Securities and Exchange Commission (SEC) after the market closes on December 30, 2014. The 2013 Form 10-K will include results for the fiscal years ended December 31, 2013 and December 31, 2012, and restated results for the fiscal year ended December 31, 2011. The company previously announced on November 12, 2014 that it expected to complete its restatement and related audits, and to file the 2013 Form 10-K by the middle of December.
AxelaCare Appoints Daniel C. Buning Chief Operating Officer
Business Wire - Tue Dec 16, 9:00AM CST
AxelaCare, a leading U.S. home intravenous therapy provider, announced today that Daniel C. Buning was appointed to serve as the company's chief operating officer.
MedAssets, Procured Health Tie Up for Value Analysis Models - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 03, 5:50PM CST
MedAssets, Inc. (MDAS) recently announced a partnership with Procured Health to deliver a comprehensive approach for implementing better clinical value analysis programs.
MDAS: 19.81 (+0.18), PINC: 36.37 (+0.53), ATHN: 134.60 (+4.95)
Accretive Health: Completion Of The Restatement Is 3 Weeks Away - Buy Before Others Notice
Out of Favor Investing - Seeking Alpha - Sat Nov 15, 10:39AM CST
The Accretive Health (OTCPK: ACHI ) story is lengthy. To summarize, ACHI performs revenue cycle management (RCM) services for hospitals. A few years ago an employee lost a laptop in Minnesota and as a result Accretive lost a customer, was forced to...
Accretive Health Reports Inducement Grant
Business Wire - Wed Nov 12, 4:00PM CST
Accretive Health, Inc. (OTC Pink: ACHI) today announced that, in connection with the appointment of David Mason as the company's chief strategy officer, on November 11, 2014, Accretive Health granted to Mason a nonstatutory stock option and shares of restricted common stock (collectively the "Inducement Grants"
as an inducement material to Mason's acceptance of employment with the company.
Accretive Health Names David Mason as Chief Strategy Officer
Business Wire - Tue Nov 11, 7:03AM CST
Accretive Health, Inc. (OTC Pink: ACHI) today announced that it has appointed David Mason as chief strategy officer, effective today.
Blue Cross Blue Shield of Arizona Advantage Adds Executive Leadership
PR Newswire - Mon Aug 11, 4:55PM CDT
Blue Cross® Blue Shield® of Arizona Advantage (BCBSAZ Advantage), an affiliate of Blue Cross Blue Shield of Arizona (BCBSAZ), has named Dave Firdaus as Chief Executive Officer. BCBSAZ Advantage is a joint venture between Banner Health and BCBSAZ to sell Medicare products. Firdaus previously served as Senior Vice President of Population Health for Accretive Health, Inc.
Accretive Health Names Peter Csapo as CFO and Treasurer
Business Wire - Thu Aug 07, 7:01AM CDT
Accretive Health, Inc. (OTC Pink: ACHI) today announced that it has appointed Peter Csapo, CPA, former chief financial officer and area senior vice president for VHA, Inc., as senior vice president, chief financial officer and treasurer, effective Tuesday, August 12.
OTC Stocks Latest Trading News: Bioadaptives, Inc. Sigma Labs, Inc. Vape Holdings, Inc. Accretive Health, Inc. Osage Exploration and Development, Inc.
PR Newswire Europe - Tue Jul 15, 7:03AM CDT
LONDON, July 15, 2014 /PRNewswire/ --
Accretive Health Names Emad Rizk, M.D. as President and CEO
Business Wire - Thu Jul 10, 7:00AM CDT
Accretive Health, Inc. (OTC Pink: ACHI) today announced that its Board of Directors has appointed Emad Rizk, M.D., president of McKesson Health Solutions, as Chief Executive Officer, President, and a member of the Board of Directors, effective July 21, 2014.
Accretive Health to Present at the 33rd Annual J.P. Morgan Healthcare Conference
Business Wire - Mon Jan 05, 4:50PM CST
Accretive Health, Inc. (OTC Pink: ACHI) today announced its management team will present at the 33rd Annual J.P. Morgan Healthcare Conference on Thursday, January 15th 2015 at 9:00 am PST in San Francisco, where management will discuss the Company's operations and business.
JPM: 59.67 (+0.10)
Accretive Health Completes Financial Restatement and Provides Business Update
Business Wire - Tue Dec 30, 3:00PM CST
--Timing of revenue recognition places emphasis on cash generated from customer contracts; company introduces new non-GAAP measures
Accretive Health - Pending Restatement Offers A 1:4 Risk/Reward With A Near-Term Catalyst
Sententia Capital - Seeking Alpha - Wed Dec 24, 5:00AM CST
Accretive Health - Long Sententia Capital Management December 2014 Ticker: OTCPK:ACHI Mkt cap: $786m Price: $8.60 Intrinsic value: $11 Recommendation : Accretive Health is a buy at $8 with a base case of $11, representing 35%...
Accretive Health Provides Updated Timeline for Completion of Restatement
Business Wire - Fri Dec 19, 6:35PM CST
Accretive Health, Inc. (OTC Pink: ACHI) today announced that it is in the final stages of completing its financial restatement. The Company currently expects to file its Annual Report on Form 10-K for the year ended December 31, 2013 with the Securities and Exchange Commission (SEC) after the market closes on December 30, 2014. The 2013 Form 10-K will include results for the fiscal years ended December 31, 2013 and December 31, 2012, and restated results for the fiscal year ended December 31, 2011. The company previously announced on November 12, 2014 that it expected to complete its restatement and related audits, and to file the 2013 Form 10-K by the middle of December.
AxelaCare Appoints Daniel C. Buning Chief Operating Officer
Business Wire - Tue Dec 16, 9:00AM CST
AxelaCare, a leading U.S. home intravenous therapy provider, announced today that Daniel C. Buning was appointed to serve as the company's chief operating officer.
MedAssets, Procured Health Tie Up for Value Analysis Models - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 03, 5:50PM CST
MedAssets, Inc. (MDAS) recently announced a partnership with Procured Health to deliver a comprehensive approach for implementing better clinical value analysis programs.
MDAS: 19.81 (+0.18), PINC: 36.37 (+0.53), ATHN: 134.60 (+4.95)
Accretive Health: Completion Of The Restatement Is 3 Weeks Away - Buy Before Others Notice
Out of Favor Investing - Seeking Alpha - Sat Nov 15, 10:39AM CST
The Accretive Health (OTCPK: ACHI ) story is lengthy. To summarize, ACHI performs revenue cycle management (RCM) services for hospitals. A few years ago an employee lost a laptop in Minnesota and as a result Accretive lost a customer, was forced to...
Accretive Health Reports Inducement Grant
Business Wire - Wed Nov 12, 4:00PM CST
Accretive Health, Inc. (OTC Pink: ACHI) today announced that, in connection with the appointment of David Mason as the company's chief strategy officer, on November 11, 2014, Accretive Health granted to Mason a nonstatutory stock option and shares of restricted common stock (collectively the "Inducement Grants"
as an inducement material to Mason's acceptance of employment with the company. Accretive Health Names David Mason as Chief Strategy Officer
Business Wire - Tue Nov 11, 7:03AM CST
Accretive Health, Inc. (OTC Pink: ACHI) today announced that it has appointed David Mason as chief strategy officer, effective today.
Blue Cross Blue Shield of Arizona Advantage Adds Executive Leadership
PR Newswire - Mon Aug 11, 4:55PM CDT
Blue Cross® Blue Shield® of Arizona Advantage (BCBSAZ Advantage), an affiliate of Blue Cross Blue Shield of Arizona (BCBSAZ), has named Dave Firdaus as Chief Executive Officer. BCBSAZ Advantage is a joint venture between Banner Health and BCBSAZ to sell Medicare products. Firdaus previously served as Senior Vice President of Population Health for Accretive Health, Inc.
Accretive Health Names Peter Csapo as CFO and Treasurer
Business Wire - Thu Aug 07, 7:01AM CDT
Accretive Health, Inc. (OTC Pink: ACHI) today announced that it has appointed Peter Csapo, CPA, former chief financial officer and area senior vice president for VHA, Inc., as senior vice president, chief financial officer and treasurer, effective Tuesday, August 12.
OTC Stocks Latest Trading News: Bioadaptives, Inc. Sigma Labs, Inc. Vape Holdings, Inc. Accretive Health, Inc. Osage Exploration and Development, Inc.
PR Newswire Europe - Tue Jul 15, 7:03AM CDT
LONDON, July 15, 2014 /PRNewswire/ --
Accretive Health Names Emad Rizk, M.D. as President and CEO
Business Wire - Thu Jul 10, 7:00AM CDT
Accretive Health, Inc. (OTC Pink: ACHI) today announced that its Board of Directors has appointed Emad Rizk, M.D., president of McKesson Health Solutions, as Chief Executive Officer, President, and a member of the Board of Directors, effective July 21, 2014.
